
Feb 20 (Reuters) - Incyte Corp INCY.O:
INCYTE AND GENESIS THERAPEUTICS ANNOUNCE STRATEGIC AI-FOCUSED RESEARCH COLLABORATION
INCYTE CORP - RECEIVES EXCLUSIVE RIGHTS TO DEVELOP AND COMMERCIALIZE COLLABORATION PRODUCTS
INCYTE CORP - UNDER AGREEMENT, GENESIS TO RECEIVE $30 MILLION UPFRONT PAYMENT
INCYTE CORP - UNDER AGREEMENT, GENESIS ELIGIBLE FOR UP TO $295 MILLION IN MILESTONE PAYMENTS PER TARGET
INCYTE CORP - GENESIS ELIGIBLE FOR TIERED ROYALTIES ON SALES OF APPROVED PRODUCTS
Source text: ID:nBw96ftdza
Further company coverage: INCY.O